BRETT MCDONALD: Open Payments
NPI 1275376279 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 61 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $118 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $259 |
| AstraZeneca Pharmaceuticals LP | 5 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
| Astellas Pharma US Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $40 |
| Boston Scientific Corporation | 1 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| PFIZER INC. | 2 | $38 |
Products named: VRAYLAR, BREZTRI, CAPLYTA, FARXIGA, REXULTI, Veozah, MOUNJARO, WATCHMAN FLX.
Industry payments across MO — which companies pay providers there.
